Diabetes TechnologyInsulin Pumps  Infusion Sets Meters & Monitors  Software Presentations
Meters & MonitorsBlood Glucose Meters Current Continuous Monitors Future Continuous Monitors Improving Today's Meters
Future MonitoringA.Menarini Diagnostics Animas Glucose Sensor Cybiocare OHD Fovioptics InLight Solutions Kumetrix LighTouch Medical NAS - iSense NIR Diagnostics Optiscan Pindi Products RetiTech Sensors For Medicine and Science Sensys Medical Sentek Solianis Sontra SpectRx Synthetic Blood International Therasense Visual Pathways
Insurance Coverage ProblemsYour insurance company is unlikely to pay for a continuous monitoring device until these devices show a benefit to users. This 2001 policy statement from Blue Cross in Canada says: "There has been minimal published data regarding the potential clinical applications of the device, i.e. whether or not the more frequent measures of glucose ultimately result in improved diabetic management, as evidenced either by an alteration in anti-diabetic medications, or an improvement in hemoglobin A1c levels. Additionally, there is no published data regarding which diabetic patients may benefit most from more intense monitoring. Only one pilot study of nine patients has been published which reported that diabetic management based on information from a CGMS resulted in improved HbA1c levels, while the total insulin requirement remained constant. The most common changes in diabetic management were alteration in diet and changes in insulin schedule." Blue Cross lists continuous glucose monitoring system (CGMS) as "INVESTIGATIONAL/NOT MEDICALLY NECESSARY." Infrared Technology Click Here to browse our secure, on-line store for a complete selection of diabetes books at 22%-50% off their cover price. You can also download our Diabetes Mall 2008 Catalog, email our Order Form, or call us at (800) 988-4772. |
